Page last updated: 2024-09-04

carbapenems and avibactam

carbapenems has been researched along with avibactam in 45 studies

Compound Research Comparison

Studies (carbapenems)	Trials (carbapenems)	Recent Studies (post-2010) (carbapenems)	Studies (avibactam)	Trials (avibactam)	Recent Studies (post-2010) (avibactam)
7,355	147	5,277	360	16	352

Protein Interaction Comparison

Protein	Taxonomy	avibactam (IC50)
Beta-lactamase	Enterobacter cloacae	0.1
Beta-lactamase	Pseudomonas aeruginosa PAO1	0.128
Beta-lactamase TEM	Escherichia coli	0.0019

Research

Studies (45)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	10 (22.22)	24.3611
2020's	35 (77.78)	2.80

Authors

Authors	Studies
Balasubramanian, D; Mathee, K; Silver, LL; Zincke, D	1
Fernea, A; Frère, JM; Galleni, M	1
Biedenbach, DJ; de Jonge, BL; Karlowsky, JA; Kazmierczak, KM; Nichols, WW; Sahm, DF	1
Buising, KL; Cronin, K; Jeremiah, CJ; Mandrawa, CL; Poy Lorenzo, YS; Waters, MJ	1
Fisher, S; Galanis, C; Gupta, C; Kaushik, A; Lamichhane, G; Parrish, N; Story-Roller, E	1
Afsharikho, H; Barnes, MD; Bonomo, RA; Galdadas, I; Gervasio, FL; Haider, S; Healy, J; Lovera, S; Pérez-Hernández, G; Woodford, N	1
Dubois, V; Jayol, A; Kieffer, N; Nordmann, P; Ortiz De La Rosa, JM; Poirel, L	1
Hsu, AJ; Tamma, PD	1
Dillon, N; Nizet, V; Pogliano, J; Sakoulas, G; Tsunemoto, H; Ulloa, ER	1
Bajaksouzian, S; Barnes, MD; Bonomo, RA; Good, CE; Haldimann, A; Jacobs, MR; Kreiswirth, BN; Papp-Wallace, KM; Rojas, LJ; Taracila, MA; van Duin, D	1
Cano, Á; Castón, JJ; García-Gutiérrez, M; Gracia-Ahufinger, I; Guzmán-Puche, J; Marfil-Pérez, E; Martínez-Martínez, L; Natera, AM; Pérez-Nadales, E; Recio, M; Torre-Cisneros, J	1
Kazmierczak, K; Spiliopoulou, I; Stone, GG	1
Antonelli, A; Cannatelli, A; Chiarelli, A; Di Pilato, V; Gatsch, C; Giani, T; Luzzaro, F; Rossolini, GM; Sennati, S; Spanu, T; Stefani, S	1
Ackley, R; Anderson, WE; Capraro, GA; Meredith, J; Minor, S; Polk, C; Roshdy, D	1
Carone, G; Dalfino, L; De Robertis, A; Del Prete, R; Mosca, A; Romanelli, F; Stufano, M	1
Ashraf, T; Barathan, G; Darwish, D; Ghazawi, A; Hashmey, R; Pál, T; Rizvi, TA; Sonnevend, Á	1
Arend, LNVS; Bail, L; Ito, CAS; Nogueira, KDS; Tuon, FF	1
Chatzidimitriou, D; Chatzidimitriou, M; Chatzivasileiou, P; Chatzopoulou, F; Katsifa, E; Kavvada, A; Kyriazidi, M; Mavridou, M; Meletis, G; Mitka, S; Rousis, D; Sakellariou, G; Theodoros, L; Vagdatli, E	1
Hsueh, PR; Huang, YT; Kuo, YW; Liao, CH; Teng, LJ	1
Cui, N; Tang, B	1
Chen, Y; Ji, J; Liu, Z; Luo, Q; Xiao, Y; Xiong, L; Ying, C; Yu, W	1
Cárdenas-Isaza, P; Lemos-Luengas, EV; Ramos-Castaneda, JA; Rentería-Valoyes, S	1
Arif, F; Hill, DM; Martin, K; Sultan-Ali, I; Velamuri, SR	1
Cai, Y; Chen, M; Cheng, Y; Li, X; Lin, H; Liu, M; Qiu, H; Que, W; Zhang, B; Zhang, H	1
Carvalhaes, CG; Castanheria, M; Duncan, LR; Mendes, RE; Sader, HS	1
Cao, J; Chen, L; Feng, L; Wang, L; Yao, Z; Zhang, X; Zhang, Y; Zhao, Y; Zheng, S; Zhou, T	1
Bai, F; Chen, S; Cheng, Z; Jin, Y; Pan, X; Wei, X; Wu, W; Xu, C	1
Dartois, V; Dick, T; Negatu, DA; Zimmerman, MD	1
Angarano, R; Arena, F; Curci, A; De Nittis, R; La Bella, G; La Salandra, G; Lopizzo, T; Lupo, L; Manti, B; Mosca, A	1
Gill, CM; Nicolau, DP	2
Aiezza, N; Andriani, L; Coppi, M; Di Pilato, V; Giani, T; Luzzaro, F; Principe, L; Ricci, S; Rossolini, GM	1
Chen, Y; Hu, Q; Liu, YP; Long, WM; Qu, J; Qu, Q; Wang, Q; Wu, XL; Xiao, YW; Xu, TT; Zhuang, HH	1
Chen, J; Jia, W; Jing, R; Li, J; Liu, Y; Sun, G; Sun, H; Wang, T; Xu, X; Xu, Y; Zhang, G	1
Coppi, M; Di Pilato, V; Montenora, I; Riccobono, E; Rossolini, GM; Salvetti, S	1
Gu, Y; Hu, D; Hu, M; Liang, R; Wang, D; Wang, M; Zhu, M	1
Hu, C; Liu, Y; Lv, X; Qu, J; Xu, J; Zhong, C	1
Kamat, S; Karlowsky, JA; Mohamed, N; Sahm, DF; Wise, MG	1
Lukovic, B; Petrovic, I; Zornic, S	1
Aldieri, C; Badalucco Ciotta, F; Bassetti, M; Calabresi, A; Cattardico, G; Cattelan, AM; Corcione, S; Cortegiani, A; D'Amico, F; De Rosa, FG; Del Bono, V; Del Puente, F; Di Meco, G; Di Pilato, V; Fanelli, C; Francisci, D; Giacobbe, DR; Giacomini, M; Gori, A; Graziani, L; Lombardi, A; Losito, AR; Marchese, A; Marelli, C; Mazzitelli, M; Merli, M; Mikulska, M; Milazzo, M; Momesso, E; Mularoni, A; Oltolini, C; Pallotto, C; Pontali, E; Raffaelli, F; Russelli, G; Serino, FS; Signori, A; Spinicci, M; Torti, C; Trecarichi, EM; Vena, A	1
Bouvier, M; Le Terrier, C; Nordmann, P; Poirel, L	1
Ahmed, A; Chryssanthou, E; Davies Forsman, L; Fröberg, G	1
Feng, Y; Ma, K; McNally, A; Zong, Z	1
Gill, CM; Lee, SY; Nicolau, DP	1
Gong, F; Liu, J; Lu, L; Shao, Z; Shi, K; Tang, S; Zheng, Z	1

Reviews

2 review(s) available for carbapenems and avibactam

Article	Year
Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms. Journal of the Pediatric Infectious Diseases Society, 2019, Jul-01, Volume: 8, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Boronic Acids; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Meropenem; Tazobactam	2019
Use of carbapenems in the combined treatment of emerging ceftazidime/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: Report of a case and review of the literature. Journal of global antimicrobial resistance, 2020, Volume: 22 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Drug Combinations; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pneumonia	2020

Article

Year

Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms.

Journal of the Pediatric Infectious Diseases Society, 2019, Jul-01, Volume: 8, Issue:3

Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Boronic Acids; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Meropenem; Tazobactam

2019

Use of carbapenems in the combined treatment of emerging ceftazidime/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: Report of a case and review of the literature.

Journal of global antimicrobial resistance, 2020, Volume: 22

Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Drug Combinations; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pneumonia

2020

Other Studies

43 other study(ies) available for carbapenems and avibactam

Article	Year
Characterization of a Carbapenem-Hydrolyzing Enzyme, PoxB, in Pseudomonas aeruginosa PAO1. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:2 Topics: Azabicyclo Compounds; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Gene Deletion; Gene Expression Regulation, Bacterial; Imipenem; Meropenem; Microbial Sensitivity Tests; Operon; Porins; Pseudomonas aeruginosa; Thienamycins	2016
Kinetics of the Interaction between BAL29880 and LK157 and the Class C β-Lactamase CHE-1. Antimicrobial agents and chemotherapy, 2016, Jan-04, Volume: 60, Issue:3 Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Enterobacter cloacae; Monobactams; Phenylurea Compounds	2016
In Vitro Susceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014). Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:5 Topics: Azabicyclo Compounds; beta-Lactamases; Carbapenems; Ceftazidime; Enterobacteriaceae; Microbial Sensitivity Tests	2016
Carbapenemase-producing Klebsiella pneumoniae: a major clinical challenge. The Medical journal of Australia, 2016, Apr-18, Volume: 204, Issue:7 Topics: Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Carbapenems; Ceftazidime; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Metronidazole; Middle Aged; Pancreatic Diseases; Teicoplanin	2016
Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus. Future microbiology, 2017, Volume: 12 Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Thienamycins	2017
Defining the architecture of KPC-2 Carbapenemase: identifying allosteric networks to fight antibiotics resistance. Scientific reports, 2018, 08-27, Volume: 8, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Drug Resistance, Microbial; Klebsiella pneumoniae; Microbial Sensitivity Tests; Protein Structure, Secondary	2018
Acquisition of Extended-Spectrum β-Lactamase GES-6 Leading to Resistance to Ceftolozane-Tazobactam Combination in Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:1 Topics: Amino Acid Substitution; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Gene Expression; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2019
Avibactam Sensitizes Carbapenem-Resistant NDM-1-Producing Klebsiella pneumoniae to Innate Immune Clearance. The Journal of infectious diseases, 2019, 07-02, Volume: 220, Issue:3 Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Humans; Immunity, Innate; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests	2019
Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:8 Topics: Acylation; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Escherichia coli; Humans; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests	2019
In vitro activity of ceftazidime/avibactam against isolates of carbapenem-non-susceptible Enterobacteriaceae collected during the INFORM global surveillance programme (2015-17). The Journal of antimicrobial chemotherapy, 2020, 02-01, Volume: 75, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Enterobacteriaceae; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult	2020
Results of the Italian infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-IT): activity of ceftazidime/avibactam against Enterobacterales isolated from urine. The Journal of antimicrobial chemotherapy, 2020, 04-01, Volume: 75, Issue:4 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Drug Combinations; Italy; Microbial Sensitivity Tests	2020
Meropenem-Vaborbactam versus Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Antimicrobial agents and chemotherapy, 2020, 04-21, Volume: 64, Issue:5 Topics: Aged; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Boronic Acids; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Cohort Studies; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Humans; Male; Meropenem; Middle Aged; Retrospective Studies; Treatment Outcome; Urinary Tract Infections	2020
In Vitro Activity of Ceftazidime/Avibactam Alone and in Combination With Fosfomycin and Carbapenems Against KPC-producing Klebsiella Pneumoniae. The new microbiologica, 2020, Volume: 43, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests	2020
In vitro efficacy of ceftazidime-avibactam, aztreonam-avibactam and other rescue antibiotics against carbapenem-resistant Enterobacterales from the Arabian Peninsula. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 99 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Drug Combinations; Drug Resistance, Bacterial; Fosfomycin; Humans; Microbial Sensitivity Tests; Middle East; Tigecycline	2020
The activity of ceftazidime/avibactam against carbapenem-resistant Infectious diseases (London, England), 2021, Volume: 53, Issue:5 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenems; Ceftazidime; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2021
Ceftazidime/avibactam and eravacycline susceptibility of carbapenem-resistant Klebsiella pneumoniae in two Greek tertiary teaching hospitals. Acta microbiologica et immunologica Hungarica, 2021, Jun-21, Volume: 68, Issue:2 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Carbapenems; Ceftazidime; Greece; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tetracyclines	2021
Comparison of Etest and broth microdilution for evaluating the susceptibility of Staphylococcus aureus and Streptococcus pneumoniae to ceftaroline and of carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa to ceftazidime/avibactam. Journal of global antimicrobial resistance, 2021, Volume: 26 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftaroline; Ceftazidime; Cephalosporins; Disk Diffusion Antimicrobial Tests; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae	2021
[Several key points that need to be concerned in the clinical application of ceftazidime/avibactam]. Zhonghua yi xue za zhi, 2021, Nov-09, Volume: 101, Issue:41 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Drug Resistance, Multiple, Bacterial; Klebsiella pneumoniae; Microbial Sensitivity Tests	2021
Frontiers in cellular and infection microbiology, 2021, Volume: 11 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Humans; Microbial Sensitivity Tests; Sepsis	2021
In vitro activity of ceftazidime/avibactam against Gram-negative strains in Colombia 2014-2018. Journal of global antimicrobial resistance, 2022, Volume: 29 Topics: Adult; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Ceftazidime; Child; Colombia; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2022
Analysis of Ceftazidime/Avibactam Use for Treating Carbapenem-Resistant Infections in Critically Ill Patients With Thermal or Inhalation Injuries. Journal of burn care & research : official publication of the American Burn Association, 2022, 07-01, Volume: 43, Issue:4 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Burns; Carbapenems; Ceftazidime; Critical Illness; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests	2022
Rapid, simple, and economical LC-MS/MS method for simultaneous determination of ceftazidime and avibactam in human plasma and its application in therapeutic drug monitoring. Journal of clinical pharmacy and therapeutics, 2022, Volume: 47, Issue:9 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenems; Ceftazidime; Chromatography, Liquid; Drug Combinations; Drug Monitoring; Humans; Microbial Sensitivity Tests; Tandem Mass Spectrometry	2022
Antimicrobial activity of cefepime/zidebactam (WCK 5222), a β-lactam/β-lactam enhancer combination, against clinical isolates of Gram-negative bacteria collected worldwide (2018-19). The Journal of antimicrobial chemotherapy, 2022, 09-30, Volume: 77, Issue:10 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Cyclooctanes; Enterobacteriaceae; Gram-Negative Bacteria; Hydrazines; Lactams; Microbial Sensitivity Tests; Piperidines; Pseudomonas aeruginosa; Tazobactam	2022
Rapid ResaCeftazidime-Avibactam Journal of clinical microbiology, 2022, 09-21, Volume: 60, Issue:9 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Enterobacteriaceae; Microbial Sensitivity Tests	2022
Development of Resistance to Eravacycline by Klebsiella pneumoniae and Collateral Sensitivity-Guided Design of Combination Therapies. Microbiology spectrum, 2022, 10-26, Volume: 10, Issue:5 Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Drug Collateral Sensitivity; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Porins; Protease La; Proteomics; Tetracyclines	2022
Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease. Antimicrobial agents and chemotherapy, 2022, 09-20, Volume: 66, Issue:9 Topics: Amoxicillin; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cefuroxime; Humans; Lactams; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium abscessus	2022
In vitro activity of ceftazidime/avibactam against carbapenem-nonsusceptible Klebsiella penumoniae isolates collected during the first wave of the SARS-CoV-2 pandemic: a Southern Italy, multicenter, surveillance study. Journal of global antimicrobial resistance, 2022, Volume: 31 Topics: Carbapenems; Ceftazidime; COVID-19; Humans; Klebsiella; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pandemics; SARS-CoV-2	2022
Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2022, 12-23, Volume: 78, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Drug Combinations; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2022
Deciphering variable resistance to novel carbapenem-based β-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2023, Volume: 29, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Disease Outbreaks; Drug Combinations; Humans; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests	2023
Carbapenem-resistant Pseudomonas aeruginosa: an assessment of frequency of isolation from ICU versus non-ICU, phenotypic and genotypic profiles in a multinational population of hospitalized patients. Antimicrobial resistance and infection control, 2022, 11-30, Volume: 11, Issue:1 Topics: Carbapenems; Cefepime; Ceftazidime; Phenotype; Pseudomonas aeruginosa; Tazobactam	2022
Efficacy and mortality of ceftazidime/avibactam-based regimens in carbapenem-resistant Gram-negative bacteria infections: A retrospective multicenter observational study. Journal of infection and public health, 2023, Volume: 16, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Ceftazidime; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Kidney Diseases; Microbial Sensitivity Tests; Retrospective Studies	2023
Microbiology spectrum, 2023, 06-15, Volume: 11, Issue:3 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Carbapenems; Cefepime; Microbial Sensitivity Tests; Tigecycline	2023
Citrobacter freundii resistant to novel β-lactamase inhibitor combinations and cefiderocol, co-producing class A, B and D carbapenemases encoded by transferable plasmids. The Journal of antimicrobial chemotherapy, 2023, 07-05, Volume: 78, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cefiderocol; Citrobacter freundii; Drug Combinations; Humans; Microbial Sensitivity Tests; Plasmids	2023
In vitro activity of ceftazidime/avibactam, imipenem/relebactam and meropenem/vaborbactam alone or in combination with polymyxin B against carbapenem resistant Acinetobacter baumannii. The Journal of antibiotics, 2023, Volume: 76, Issue:9 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenems; Ceftazidime; Drug Combinations; Imipenem; Meropenem; Microbial Sensitivity Tests; Polymyxin B	2023
Real-world effectiveness of ceftazidime/avibactam versus polymyxin B in treating patients with carbapenem-resistant Gram-negative bacterial infections. International journal of antimicrobial agents, 2023, Volume: 62, Issue:2 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Drug Combinations; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymyxin B; Retrospective Studies	2023
In vitro activity of aztreonam-avibactam against Enterobacterales isolates collected in Latin America, Africa/Middle East, Asia, and Eurasia for the ATLAS Global Surveillance Program in 2019-2021. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2023, Volume: 42, Issue:9 Topics: Anti-Bacterial Agents; Asia; Aztreonam; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Enterobacteriaceae; Humans; Latin America; Microbial Sensitivity Tests; Middle East	2023
In vitro activity of imipenem/relebactam and ceftazidime/avibactam against carbapenem-resistant Klebsiella pneumoniae from blood cultures in a University hospital in Serbia. Acta microbiologica et immunologica Hungarica, 2023, Sep-21, Volume: 70, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Colistin; Drug Combinations; Hospitals, University; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serbia	2023
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape. The Journal of antimicrobial chemotherapy, 2023, 10-03, Volume: 78, Issue:10 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Disease Susceptibility; Drug Combinations; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Sepsis	2023
Impact of acquired broad-spectrum β-lactamases on susceptibility to oral penems/carbapenems (tebipenem, sulopenem, and faropenem) alone or in combination with avibactam and taniborbactam β-lactamase inhibitors in Antimicrobial agents and chemotherapy, 2023, 10-18, Volume: 67, Issue:10 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Escherichia coli; Meropenem; Microbial Sensitivity Tests	2023
The Antimicrobial agents and chemotherapy, 2023, 10-18, Volume: 67, Issue:10 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Drug Combinations; Imipenem; Microbial Sensitivity Tests; Mycobacterium abscessus	2023
Hijacking a small plasmid to confer high-level resistance to aztreonam-avibactam and ceftazidime-avibactam. International journal of antimicrobial agents, 2023, Volume: 62, Issue:5 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Escherichia coli; Microbial Sensitivity Tests; Plasmids	2023
Activity of novel β-lactam/β-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2023, Dec-01, Volume: 78, Issue:12 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Imipenem; Lactams; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2023
Ceftazidime/avibactam combined with colistin: a novel attempt to treat carbapenem-resistant Gram-negative bacilli infection. BMC infectious diseases, 2023, Oct-20, Volume: 23, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Ceftazidime; Colistin; Gram-Negative Bacteria; Humans; Retrospective Studies	2023